ClinicalTrials.Veeva

Menu

Restructuring Body Experience in Anorexia Nervosa: Virtual Reality Functionality-Focused Mirror Exposure (VR-FME)

C

Catholic University of the Sacred Heart

Status

Begins enrollment this month

Conditions

Anorexia Nervosa

Treatments

Other: VR -FME

Study type

Interventional

Funder types

Other

Identifiers

NCT06852183
CNR_08/2024

Details and patient eligibility

About

Background: Body image disturbance remains a core therapeutic challenge in Anorexia Nervosa (AN) treatment, necessitating innovative intervention approaches. This study protocol describes a randomized controlled trial investigating Virtual Reality Functionality-Focused Mirror Exposure (VR-FME), a novel intervention targeting the perceptual, affective, and cognitive dimensions of body image disturbance in AN patients.

Methods: This single-blind, parallel-group randomized controlled trial will evaluate the efficacy of VR-FME as an adjunct to treatment as usual (TAU). Participants with AN will be randomly allocated to receive either VR-FME combined with TAU or TAU alone. The intervention specifically addresses altered body image through immersive virtual reality technology, providing controlled exposure and cognitive restructuring opportunities.

Primary Outcome: The primary outcome measure will assess changes in body image disturbance severity and core eating disorder symptomatology. We hypothesize that the integration of VR-FME with TAU will demonstrate superior therapeutic outcomes compared to TAU alone.

Significance: This protocol represents an innovative approach to addressing body image disturbance in AN, potentially enhancing current therapeutic strategies through the integration of immersive virtual reality technology. The findings will contribute to the evolving landscape of technology-enhanced interventions for eating disorders.

Enrollment

40 estimated patients

Sex

Female

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: between 16-24.
  • Primary diagnosis of Anorexia Nervosa
  • BMI > 14.5
  • No current diagnosis or previous diagnosis for neurological disorders
  • Females
  • Fluency in Italian
  • Ability to provide informed consent (and parental consent for minors)

Exclusion criteria

  • Anorexia Nervosa is not a primary diagnosis
  • Age < 16
  • BMI < 14.5
  • Conditions that could interfere with VR use (e.g., neurological conditions, severe visual impairments, vestibular disorders)
  • Males
  • Substance abuse, active suicidal ideation, severe psychiatric comorbidities
  • Pregrancy
  • Ongoing participation in other clinical trials
  • Inability to commit to the full duration of the study

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

VR-FME
Experimental group
Description:
The VR-FME protocol integrates multiple therapeutic approaches within an immersive virtual environment. Each 60-minute session begins with embodiment induction, where participants experience synchronized multisensory stimulation to create embodiment over their virtual body. Then, various therapeutic techniques - including cognitive dissonance mirror exposure, functionality-focused mirror exposure, and compassionate body scan exercises - will be used. Each of the 8 sessions will work on a specific aspect to address different levels of body image disturbance. The intervention structure begins with an initial assessment and familiarization phase in Week 1, followed by intensive body-focused work in Weeks 2-4.
Treatment:
Other: VR -FME
TAU
Active Comparator group
Description:
For the entire duration of the protocol, both the experimental group (VR-FME) and the control groups will carry out the standard intervention protocol proposed by the treatment center, which consists of an outpatient program that includes weekly internal-nutritional visits, psychotherapy and NPIA assessments to also monitor the pharmacological therapy. Therefore, if the experimental group carries out the standard procedure (Treatment As Usual - TAU) in addition to the VR body image protocol (VR-FME + TAU), the control group will be subjected to the standard treatment path (TAU).
Treatment:
Other: VR -FME

Trial contacts and locations

0

Loading...

Central trial contact

Giulia Brizzi, MSC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems